Kiniksa Pharmaceuticals Cash from Financing (TTM) Analysis

Kiniksa Pharmaceuticals Ltd (KNSA)

17.95 +0.34 (+1.93%) USD | NASDAQ | Apr 26, 15:39

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	1.495M
September 30, 2023	1.99M
June 30, 2023	1.799M
March 31, 2023	2.183M
December 31, 2022	2.516M
September 30, 2022	2.538M
June 30, 2022	4.857M
March 31, 2022	5.202M
December 31, 2021	5.885M
September 30, 2021	5.385M
June 30, 2021	149.10M
March 31, 2021	225.78M
December 31, 2020	227.09M

Date	Value
September 30, 2020	226.75M
June 30, 2020	80.40M
March 31, 2020	3.334M
December 31, 2019	84.11M
September 30, 2019	84.02M
June 30, 2019	83.21M
March 31, 2019	239.11M
December 31, 2018	346.74M
September 30, 2018	346.44M
June 30, 2018	347.21M
March 31, 2018	190.81M
December 31, 2017	39.87M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.495M

Minimum

Dec 2023

227.09M

Maximum

Dec 2020

63.03M

Average

5.385M

Median

Sep 2021

Cash from Financing (TTM) Benchmarks